CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin Plus Asparaginase (DA-EPOCH-A) for Adults With Acute Lymphoblastic Leukemia/Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02538926
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:05.456051+00:00
Published At: 2018-11-14T00:00:00+00:00
Record Updated At: 2018-11-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["B Acute Lymphoblastic Leukemia", "B Lymphoblastic Lymphoma", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent B Lymphoblastic Lymphoma", "Recurrent T Lymphoblastic Leukemia/Lymphoma", "Refractory B Lymphoblastic Lymphoma", "Refractory T Lymphoblastic Lymphoma", "T Acute Lymphoblastic Leukemia", "T Lymphoblastic Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-11-14"
protocolSection.identificationModule.nctId: "NCT02538926"
protocolSection.identificationModule.officialTitle: "A Phase II Study of Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin Plus Asparaginase (DA-EPOCH-A) for Adults With Acute Lymphoblastic Leukemia/Lymphoma"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.